What is Humacyte, Inc. Common Stock's Market Cap?

Humacyte, Inc. Common Stock's Market Cap is $165.3M, based on as-reported figures from SEC (XBRL) filings.

What is Humacyte, Inc. Common Stock's Enterprise Value?

Humacyte, Inc. Common Stock's Enterprise Value is $151.5M, based on as-reported figures from SEC (XBRL) filings.

What is Humacyte, Inc. Common Stock's Price / Sales?

Humacyte, Inc. Common Stock's Price / Sales is 77.9×, based on as-reported figures from SEC (XBRL) filings.

What is Humacyte, Inc. Common Stock's EV / Revenue?

Humacyte, Inc. Common Stock's EV / Revenue is 71.4×, based on as-reported figures from SEC (XBRL) filings.

What is Humacyte, Inc. Common Stock's EV / EBITDA?

Humacyte, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Humacyte, Inc. Common Stock's Revenue (TTM)?

Humacyte, Inc. Common Stock's Revenue (TTM) is $2.1M, based on as-reported figures from SEC (XBRL) filings.

What is Humacyte, Inc. Common Stock's Net Income (TTM)?

Humacyte, Inc. Common Stock's Net Income (TTM) is -$96.7M, based on as-reported figures from SEC (XBRL) filings.

What is Humacyte, Inc. Common Stock's EBITDA?

Humacyte, Inc. Common Stock's EBITDA is -$105.8M, based on as-reported figures from SEC (XBRL) filings.

What is Humacyte, Inc. Common Stock's Diluted EPS (TTM)?

Humacyte, Inc. Common Stock's Diluted EPS (TTM) is -0.35, based on as-reported figures from SEC (XBRL) filings.

What is Humacyte, Inc. Common Stock's EBITDA Margin?

Humacyte, Inc. Common Stock's EBITDA Margin is -4988.0%, based on as-reported figures from SEC (XBRL) filings.

Humacyte, Inc. Common Stock (HUMA) Financial Statements

Humacyte, Inc. Common Stock

SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

FIGI BBG00XPPT7T6

XNAS · usd

0.59▼ 0.01 (-1.65%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close0.60

Day's Range0.58 – 0.61

52-Week Range0.53 – 2.55

Volume2.3M

Avg Volume7.8M

Share Statistics

Shares Outstanding

Employees184

ExchangeXNAS

Listed2021-08-27

Share count as of August 10, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Humacyte, Inc. Common Stock (HUMA)

What is Humacyte, Inc. Common Stock's Market Cap?: Humacyte, Inc. Common Stock's Market Cap is $165.3M, based on as-reported figures from SEC (XBRL) filings.
What is Humacyte, Inc. Common Stock's Enterprise Value?: Humacyte, Inc. Common Stock's Enterprise Value is $151.5M, based on as-reported figures from SEC (XBRL) filings.
What is Humacyte, Inc. Common Stock's Price / Sales?: Humacyte, Inc. Common Stock's Price / Sales is 77.9×, based on as-reported figures from SEC (XBRL) filings.
What is Humacyte, Inc. Common Stock's EV / Revenue?: Humacyte, Inc. Common Stock's EV / Revenue is 71.4×, based on as-reported figures from SEC (XBRL) filings.
What is Humacyte, Inc. Common Stock's EV / EBITDA?: Humacyte, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Humacyte, Inc. Common Stock's Revenue (TTM)?: Humacyte, Inc. Common Stock's Revenue (TTM) is $2.1M, based on as-reported figures from SEC (XBRL) filings.
What is Humacyte, Inc. Common Stock's Net Income (TTM)?: Humacyte, Inc. Common Stock's Net Income (TTM) is -$96.7M, based on as-reported figures from SEC (XBRL) filings.
What is Humacyte, Inc. Common Stock's EBITDA?: Humacyte, Inc. Common Stock's EBITDA is -$105.8M, based on as-reported figures from SEC (XBRL) filings.
What is Humacyte, Inc. Common Stock's Diluted EPS (TTM)?: Humacyte, Inc. Common Stock's Diluted EPS (TTM) is -0.35, based on as-reported figures from SEC (XBRL) filings.
What is Humacyte, Inc. Common Stock's EBITDA Margin?: Humacyte, Inc. Common Stock's EBITDA Margin is -4988.0%, based on as-reported figures from SEC (XBRL) filings.